[SRNE] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 339.37%
YoY- 136.27%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 3,913 6,246 20,407 121,910 4,665 4,874 4,019 -1.77%
PBT -74,081 -33,574 -38,001 94,953 -16,137 -25,499 -12,724 224.68%
Tax -1,377 -948 -90,424 57,480 -1,398 -1,696 -701 57.04%
NP -73,864 -32,574 12,425 33,959 -14,187 -23,064 -11,957 237.79%
Tax Rate - - - -60.54% - - - -
Total Cost 77,777 38,820 7,982 87,951 18,852 27,938 15,976 188.08%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -1,887.66 -521.52 60.89 27.86 -304.12 -473.20 -297.51 243.88%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.73 -0.38 0.15 0.44 -0.20 -0.45 -0.23 116.42%
EPS Diluted -0.73 -0.38 0.15 0.44 -0.20 -0.45 -0.23 116.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.